Succulentoside E



Compound IDCDAMM02506
Common nameSucculentoside E
IUPAC name2-[[9-[3,5-dihydroxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-7-hydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-4-yl]oxy]oxane-3,4,5-triol
Molecular formulaC45H76O16

Experimental data

Retention time8.6
Adduct[M+K]+
Actual mz911.476
Theoretical mz911.476
Error0.17
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7718

Identifiers and class information

Inchi keyXLPWHCKLGKFHCL-DEHRKWKJNA-N
SmilesOC1COC(OC2CC3(C)C(CCC4C5(C)CCC(OC6OCC(O)C(OC7OCC(O)C(O)C7O)C6O)C(C)(C)C5C(O)CC43C)C8(C)CCC(C28)C(O)(C)C)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)873.086
Computed dipole moment(dipole)8.583
Total solvent accessible surface area (SASA)1136.07
Hydrophobic component of SASA (FOSA)821.028
Hydrophilic component of SASA (FISA)315.045
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2405.36
Number of hydrogen bond donors (donorHB)10
Number of hydrogen bond acceptors (accptHB)26.25
Free energy of solvation of dipole (dip^2/V)0.0306234
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0730673
Globularity descriptor (glob)0.764209
Predicted polarizability in cubic angstroms (QPpolrz)79.193
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.681
Predicted octanol/gas partition coefficient (QPlogPoct)56.39
Predicted water/gas partition coefficient (QPlogPw)41.348
Predicted octanol/water partition coefficient (QPlogPo/w)0.266
Predicted aqueous solubility (QPlogS)-4.521
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.716
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.347
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)10.194
Predicted brain/blood partition coefficient (QPlogBB)-4.057
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3.48
Predicted skin permeability, log Kp (QPlogKp)-5.694
PM3 calculated ionization potential (IP(ev))10.17
PM3 calculated electron affinity (EA(eV))-1.309
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-0.822
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)7.673
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)235.835
Number of nitrogen and oxygen atoms (#NandO)16
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P49810PSEN2Gamma-secretaseT99204SwissTargetPrediction
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction
P05230FGF1Acidic fibroblast growth factorT18639SwissTargetPrediction
P09038FGF2Basic fibroblast growth factorT31621SwissTargetPrediction
Q9Y251HPSEHeparanaseT47623SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T99204DI0320Osteoarthritis[ICD-11: FA00-FA05]P49810PSEN2
T99204DI0380Shoulder lesion[ICD-11: FB53]P49810PSEN2
T99204DI0390Soft tissue disorder[ICD-11: FB56]P49810PSEN2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T47623DI0020African trypanosomiasis[ICD-11: 1F51]Q9Y251HPSE
T47623DI0310Ocular disease[ICD-11: N.A.]Q9Y251HPSE

Copyright © 2025